HRP20050903B1 - Intravenska injekcija ne-neurotoksiäśnih aktivatora plazminogena za tretman kapi - Google Patents
Intravenska injekcija ne-neurotoksiäśnih aktivatora plazminogena za tretman kapiInfo
- Publication number
- HRP20050903B1 HRP20050903B1 HRP20050903AA HRP20050903A HRP20050903B1 HR P20050903 B1 HRP20050903 B1 HR P20050903B1 HR P20050903A A HRP20050903A A HR P20050903AA HR P20050903 A HRP20050903 A HR P20050903A HR P20050903 B1 HRP20050903 B1 HR P20050903B1
- Authority
- HR
- Croatia
- Prior art keywords
- plasminogen
- intravenous injection
- treating cerebral
- cerebral stroke
- neurotoxic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/49—Urokinase; Tissue plasminogen activator
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
- A61K38/58—Protease inhibitors from animals; from humans from leeches, e.g. hirudin, eglin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Zoology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EPPCT/EP03/04608 | 2003-05-02 | ||
| PCT/EP2003/004729 WO2004096267A1 (de) | 2003-05-02 | 2003-05-06 | Intravenöse injektion nicht-neurotoxischer plasminogen-aktivatoren zur behandlung von schlaganfall |
| PCT/EP2004/004626 WO2004096268A2 (de) | 2003-05-02 | 2004-04-30 | Intravenöse injektion nicht-neurotoxischer plasminogen-aktivatoren zur behandlung von schlaganfall |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HRP20050903A2 HRP20050903A2 (en) | 2006-08-31 |
| HRP20050903B1 true HRP20050903B1 (hr) | 2013-11-22 |
Family
ID=35610451
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20050903AA HRP20050903B1 (hr) | 2003-05-02 | 2004-04-30 | Intravenska injekcija ne-neurotoksiäśnih aktivatora plazminogena za tretman kapi |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1622639B1 (https=) |
| JP (1) | JP2006525270A (https=) |
| KR (1) | KR101212631B1 (https=) |
| BR (1) | BRPI0409865A (https=) |
| CA (1) | CA2524573A1 (https=) |
| HR (1) | HRP20050903B1 (https=) |
| NO (1) | NO337485B1 (https=) |
| NZ (1) | NZ543367A (https=) |
| PL (1) | PL1622639T3 (https=) |
| WO (1) | WO2004096268A2 (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10153601A1 (de) | 2001-11-02 | 2003-05-22 | Paion Gmbh | DSPA zur Behandlung von Schlaganfall |
| US7759506B2 (en) | 2002-02-25 | 2010-07-20 | Diffusion Pharmaceuticals Llc | Bipolar trans carotenoid salts and their uses |
| DE10342518A1 (de) * | 2003-09-12 | 2005-05-12 | Paion Gmbh | Plasminogen-Aktivatoren mit verringerter Lysin-Bindungskapazität |
| UA95903C2 (ru) | 2005-02-24 | 2011-09-26 | Дифьюжен Фармасьютикалз Ллк | Транс-каротиноиды, их синтез, лекарственная форма и применение |
| WO2008022801A1 (en) * | 2006-08-25 | 2008-02-28 | Paion Deutschland Gmbh | Method for the manufacture of a medicament for treating hemorrhagic stroke |
| EP1897554A1 (en) * | 2006-08-25 | 2008-03-12 | PAION Deutschland GmbH | Method for the manufacture of a medicament for treating hemorrhagic stroke |
| CN101687757A (zh) | 2007-04-13 | 2010-03-31 | 扩散药品有限公司 | 双极性反式类胡萝卜素作为预治疗及其在周围血管疾病的治疗中的应用 |
| WO2010144721A2 (en) | 2009-06-10 | 2010-12-16 | Arbor Vita Corporation | Model systems and treatment regimes for treatment of neurological disease |
| KR101875843B1 (ko) | 2009-06-22 | 2018-07-06 | 디퓨젼 파마슈티컬즈 엘엘씨 | 확산 촉진 화합물 및 그 화합물 단독 또는 혈전 용해제와 합쳐진 화합물의 용도 |
| JP5823671B2 (ja) * | 2009-07-27 | 2015-11-25 | 国立大学法人 新潟大学 | 免疫製剤を含む脳梗塞治療用医薬品組成物 |
| JP5823672B2 (ja) * | 2009-07-27 | 2015-11-25 | 国立大学法人 新潟大学 | 受容体シグナル伝達阻害剤を含む脳梗塞治療用医薬品組成物 |
| US8652476B2 (en) | 2009-07-27 | 2014-02-18 | Niigata University | Pharmaceutical composition for treating ischemic events |
| KR101891357B1 (ko) | 2010-06-02 | 2018-08-24 | 디퓨젼 파마슈티컬즈 엘엘씨 | 양극성 트랜스 카로티노이드의 경구용 제형 |
| ES2912042T3 (es) * | 2011-06-24 | 2022-05-24 | Nono Inc | Terapia de combinación para isquemia |
| US9241970B2 (en) | 2011-12-13 | 2016-01-26 | Nono Inc. | Therapy for subarachnoid hemorrhage and ischemia |
| US11185523B2 (en) | 2016-03-24 | 2021-11-30 | Diffusion Pharmaceuticals Llc | Use of bipolar trans carotenoids with chemotherapy and radiotherapy for treatment of cancer |
| US10617756B2 (en) | 2017-01-05 | 2020-04-14 | Shimojani, LLC | Drug regimen for treatment of cerebral ischemia |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0352119A2 (en) * | 1988-07-20 | 1990-01-24 | Schering Aktiengesellschaft | Vampire bat salivary plasminogen activators |
| WO1991005048A1 (en) * | 1989-10-03 | 1991-04-18 | Stichting Centraal Laboratorium Van De Bloedtransfusiedienst Van Het Nederlandse Rode Kruis | Mutants of the human plasminogen activator inhibitor 1 (pai-1), their preparation and use |
| EP1308166A1 (de) * | 2001-11-02 | 2003-05-07 | Paion GmbH | Desmodus Salivary Plasminogen Activator (DSPA) zur Behandlung von Schlaganfällen |
-
2004
- 2004-04-30 CA CA002524573A patent/CA2524573A1/en not_active Abandoned
- 2004-04-30 BR BRPI0409865-0A patent/BRPI0409865A/pt not_active IP Right Cessation
- 2004-04-30 JP JP2006505347A patent/JP2006525270A/ja not_active Withdrawn
- 2004-04-30 PL PL04730516T patent/PL1622639T3/pl unknown
- 2004-04-30 WO PCT/EP2004/004626 patent/WO2004096268A2/de not_active Ceased
- 2004-04-30 HR HRP20050903AA patent/HRP20050903B1/hr not_active IP Right Cessation
- 2004-04-30 KR KR1020057020820A patent/KR101212631B1/ko not_active Expired - Fee Related
- 2004-04-30 EP EP04730516A patent/EP1622639B1/de not_active Expired - Lifetime
- 2004-04-30 NZ NZ543367A patent/NZ543367A/en not_active IP Right Cessation
-
2005
- 2005-12-01 NO NO20055692A patent/NO337485B1/no not_active IP Right Cessation
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0352119A2 (en) * | 1988-07-20 | 1990-01-24 | Schering Aktiengesellschaft | Vampire bat salivary plasminogen activators |
| WO1991005048A1 (en) * | 1989-10-03 | 1991-04-18 | Stichting Centraal Laboratorium Van De Bloedtransfusiedienst Van Het Nederlandse Rode Kruis | Mutants of the human plasminogen activator inhibitor 1 (pai-1), their preparation and use |
| EP1308166A1 (de) * | 2001-11-02 | 2003-05-07 | Paion GmbH | Desmodus Salivary Plasminogen Activator (DSPA) zur Behandlung von Schlaganfällen |
| WO2003037363A2 (de) * | 2001-11-02 | 2003-05-08 | Paion Gmbh | Nicht-neurotoxische plasminogen aktivierende faktoren zur behandlung von schlaganfall |
Also Published As
| Publication number | Publication date |
|---|---|
| NZ543367A (en) | 2010-06-25 |
| EP1622639A2 (de) | 2006-02-08 |
| EP1622639B1 (de) | 2013-01-16 |
| KR101212631B1 (ko) | 2012-12-14 |
| NO337485B1 (no) | 2016-04-25 |
| KR20060020616A (ko) | 2006-03-06 |
| WO2004096268A3 (de) | 2005-04-21 |
| PL1622639T3 (pl) | 2013-06-28 |
| WO2004096268A2 (de) | 2004-11-11 |
| CA2524573A1 (en) | 2004-11-11 |
| NO20055692L (no) | 2006-01-30 |
| NO20055692D0 (no) | 2005-12-01 |
| BRPI0409865A (pt) | 2006-05-16 |
| JP2006525270A (ja) | 2006-11-09 |
| HRP20050903A2 (en) | 2006-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20050903A2 (en) | Intravenous injection of plasminogen non-neurotoxic activators for treating cerebral stroke | |
| CY1109648T1 (el) | Μη νευροτοξικοι παραγοντες ενεργοποιησης πλασμινογονου για την αγωγη εγκεφαλικου επεισοδιου | |
| DE60111570D1 (de) | Isoindolin-1-on als glukokinaseaktivatoren | |
| DE60323628D1 (de) | Intrakraniale behandlung neuropsychiatrischer krankheiten mit clostridium neurotoxinen wie botulinus toxin | |
| DK1411932T3 (da) | Kombinationsterapi med substituerede oxazolidinoner | |
| ATE387197T1 (de) | Cyanoalkylamino-derivate als protease-hemmer | |
| DK1346041T3 (da) | Terapeutiske midler og fremgangsmåder til anvendelse deraf til behandling af en amyloidogen sygdom | |
| AR028939A1 (es) | Metodo para tratar un desorden pancreatico con una neurotoxina | |
| DE50310516D1 (de) | Fredericamycin-derivate | |
| DE60306505D1 (de) | Verfahren zur behandlung von brustdrüsenerkrankungen | |
| NO20054371L (no) | Somatostatin-dopamin kimaere analoger | |
| CY1110644T1 (el) | 5,6,7-τριυδροξυεπτανοϊκο οξυ και τα αναλογα για την θεραπεια οφθαλμικων ασθενειων που σχετιζονται με υπερεκφυτικες και αγγειογενεις αντιδρασεις | |
| ES2176263T3 (es) | 5,6-dihidropironas derivadas como inhibidores de proteasa y agentes antivirus. | |
| CY1114254T1 (el) | Ενδοφλεβια ενεση μη νευροτοξικων ενεργοποιητων του πλασμινογονου για την αντιμετωπιση του εγκεφαλικου επεισοδιου | |
| ATE326947T1 (de) | Thixotropes nasenspray | |
| SE0004101D0 (sv) | New use | |
| DK1438034T3 (da) | Anvendelse af -phenyl-3-dimethylaminiopropanforbindelser til behandling af urininkontinens | |
| ATE345135T1 (de) | Tropan-derivate mit dopamin-wiederaufnahme-hemmer-wirkung für die behandlung von ischämischen erkrankungen | |
| NO20030021D0 (no) | Heterosykliske forbindelser som er inhibitorer for enzymet DPP-IV | |
| MX2023004034A (es) | Métodos de tratamiento de la dermatomiositis. | |
| IL165996A0 (en) | Novel thiophene acyl hydrazino derivatives method for preparing same use thereof as medicines pharmaceutical compositions and novel use | |
| ECSP034651A (es) | Activadores de glucocinasa isoindolin-1-ona |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A1OB | Publication of a patent application | ||
| ARAI | Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application | ||
| PPPP | Transfer of rights |
Owner name: H. LUNDBECK A/S, DK |
|
| B1PR | Patent granted | ||
| ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20170306 Year of fee payment: 14 |
|
| PBON | Lapse due to non-payment of renewal fee |
Effective date: 20180430 |